| Structure |
Chemical Name |
CAS |
MF |
 |
ENDOFECTIN LENTI Transfection Reagent |
|
|
 |
1,6-ジヒドロ-6-イミノ-3-(4-メトキシフェニル)-1-ピリダジンブタン酸·臭化水素酸塩 |
104104-50-9 |
C15H18BrN3O3 |
 |
(1E,4E)-1,5-ビス(2-メトキシフェニル)-1,4-ペンタジエン-3-オン |
39777-61-2 |
C19H18O3 |
|
|
SPERMIDINE (NNOS inhibitor) |
|
|
 |
127935GR塩酸塩 |
148642-42-6 |
C29H31N5O3·HCl |
|
|
AKT INHIBITOR VIII (AKT inhibitor) |
|
|
|
|
Amphotericin B solution (250 g/mL) |
|
|
|
|
FULVESTRANT (ER antagonist) |
|
|
|
|
AC-YVAD-PNA (CASPASE 1 chromogenic substrate) |
|
|
|
|
Antifade Mounting Medium |
|
|
|
|
MASITINIB (C-KIT inhibitor) |
|
|
 |
(S)-3-Chloro-hoMophenylalanine |
1260590-15-5 |
C10H12ClNO2 |
|
|
SANT-1 (HEDGEHOG/SMOOTHENED antagonist) |
|
|
![ピリド[4,3-d]ピリミジン-4(3H)-オン](/CAS/GIF/16952-64-0.gif) |
ピリド[4,3-d]ピリミジン-4(3H)-オン |
16952-64-0 |
C7H5N3O |
|
|
AM251 (CANNABINOID RECEPTOR antagonist) |
|
|
|
|
AZD4547 (FGFR inhibitor) |
|
|
 |
オクトレオチド塩酸塩 |
1607842-55-6 |
C49H68Cl2N10O10S2 |
![2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)-](/CAS/20211123/GIF/745051-61-0.gif) |
2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)- |
745051-61-0 |
C20H23FN2O4S2 |
|
|
BMY7378 (5-HT RECEPTOR antagonist) |
|
|
|
|
DOCETAXEL (MICROTUBULE ASSOSIATED inhibitor) |
|
|
|
|
トリプチケースソイブロス |
|
|
|
|
WH-4-023 (SRC inhibitor) |
|
|
|
|
BOUIN'S SOLUTION |
|
|
|
|
NU-7441 (DNA-PK inhibitor) |
|
|
|
|
CAL-101 (PI3K inhibitor) |
|
|
![4-[2-フェニル-5,7-ビス(トリフルオロメチル)ピラゾロ[1,5-a]ピリミジン-3-イル]フェノール](/CAS/GIF/805239-56-9.gif) |
4-[2-フェニル-5,7-ビス(トリフルオロメチル)ピラゾロ[1,5-a]ピリミジン-3-イル]フェノール |
805239-56-9 |
C20H11F6N3O |
|
|
OBATOCLAX MESYLATE (BCL-2 inhibitor) |
|
|
|
|
VELIPARIB (ABT-888) (PARP1 inhibitor) |
|
|
|
|
BRIVANIB (VEGFR inhibitor) |
|
|
|
|
Kidney function biochemical test kit |
|
|
|
|
PAZOPANIB (VEGFR inhibitor) |
|
|
|
|
ACP-196 (BTK inhibitor) |
|
|
|
|
AZ20 (ATM/ATR inhibitor) |
|
|
|
|
Wright staining solution |
|
|
|
|
A-366 (HISTONE METHYLTRANSFERASE Inhibitor) |
|
|
![1,4-Dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]amino]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylicacid3,5-dimethylesterL-Lactate](/CAS/GIF/186185-03-5.gif) |
1,4-Dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]amino]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylicacid3,5-dimethylesterL-Lactate |
186185-03-5 |
C33H42N4O6 |
|
|
S2RA (SIGMA RECEPTOR antagonist) |
|
|
 |
N-(2-メチル-1-オキソプロピル)-L-His-L-Trp-L-Ala-L-Val-D-Ala-L-His-N-メチル-L-Leu-NH2 |
124001-41-8 |
C45H65N13O8 |
|
|
MONENSIN (protein transport inhibitor) |
|
|
|
|
CEDIRANIB (VEGFR inhibitor) |
|
|
 |
BTdCPU |
1257423-87-2 |
C13H8Cl2N4OS |
|
|
MONOMETHYL AURISTATIN E (microtubule-associated inhibitor) |
|
|
![(3aS,6aβ)-ヘキサヒドロ-2-オキソ-1H-チエノ[3,4-d]イミダゾール-4α-ペンタン酸スクシンイミジル](/CAS/GIF/35013-72-0.gif) |
(3aS,6aβ)-ヘキサヒドロ-2-オキソ-1H-チエノ[3,4-d]イミダゾール-4α-ペンタン酸スクシンイミジル |
35013-72-0 |
C14H19N3O5S |
 |
N-トシル-9H-キサンテン-9-アミン |
6326-06-3 |
C20H17NO3S |
|
|
EMPAGLIFLOZIN (SGLT inhibitor) |
|
|
|
|
LEE011 (CDK inhibitor) |
|
|
|
|
TBE (5X) |
|
|
 |
アセチルコエンザイムA ナトリウム塩 |
102029-73-2 |
C23H38N7O17P3S.3Na |
|
|
PD184352 (MEK inhibitor) |
|
|
|
|
MLN9708 (20S PROTEASOME Inhibitor) |
|
|
|
|
TUBASTATIN A (HDAC inhibitor) |
|
|
 |
CU-CPT-8m |
125079-83-6 |
C14H12N4O |
![Pyridazine, 3-[[(2-chloro-6-fluorophenyl)methyl]thio]-6-(2-pyridinyl)-](/CAS/20210305/GIF/892415-28-0.gif) |
Pyridazine, 3-[[(2-chloro-6-fluorophenyl)methyl]thio]-6-(2-pyridinyl)- |
892415-28-0 |
C16H11ClFN3S |
|
|
CLOZAPINE N-OXIDE (5-HT2 antagonist) |
|
|
|
|
LEDIPASVIR (HCV PROTEASE INHIBITOR) |
|
|
|
|
BKM120 (PI3K inhibitor) |
|
|
|
|
RIPA BUFFER |
|
|
|
|
MG-132 (PROTEASOME Inhibitor) |
|
|
|
|
Spore Stain Kit |
|
|
|
|
GZD824 DIMESYLATE (BCR-ABL inhibitor) |
|
|
|
|
PYRIDONE 6 (JAK inhibitor) |
|
|
|
|
GSK1292263 (GPR agonist) |
|
|
|
|
HYDROXYUREA (DNA SYNTHESIS inhibitor) |
|
|
|
|
POLY-L-LYSINE/polylysine |
|
|
|
|
Liver function biochemical test kit |
|
|
|
|
Ampicillin (100mg/ml,1000X) |
|
|
 |
ソリフェナシン |
242478-37-1 |
C23H26N2O2 |
 |
Guanosine 5'-(trihydrogen diphosphate), 3'-O-methyl- (9CI) |
78771-34-3 |
C11H17N5O11P2 |
|
|
CABOZANTINIB (VEGFR inhibitor) |
|
|
|
|
40% Acr-Bis (39:1) |
|
|
|
|
ML324 (HISTONE DEMETHYLASE inhibitor) |
|
|
|
|
ROSCOVITINE (SELICICLIB, CYC202) (CDK2 inhibitor) |
|
|
 |
BD1063二塩酸塩 |
206996-13-6 |
C13H19Cl3N2 |
|
|
FLAVOPIRIDOL HCL (CDK inhibitor) |
|
|
|
|
FORETINIB (C-MET inhibitor) |
|
|
 |
スパルストロニンB |
1259330-61-4 |
C15H8O5 |
|
|
SAG (HEDGEHOG/SMOOTHENED agonist) |
|
|
|
|
Serum blocking agent |
|
|
|
|
Kanamycin (10mg/ml,1000X) |
|
|
|
|
Fast protein stain |
|
|
|
|
Syphilis toluidine red non-heated serum test diagnostic reagent |
|
|
![1-[[3-[2-(4-クロロフェニル)エチル]-1,2,4-オキサジアゾール-5-イル]メチル]-7-メチル-7H-プリン-6-オン](/CAS/20200611/GIF/1883711-97-4.gif) |
1-[[3-[2-(4-クロロフェニル)エチル]-1,2,4-オキサジアゾール-5-イル]メチル]-7-メチル-7H-プリン-6-オン |
1883711-97-4 |
C17H15ClN6O2 |
|
|
REGADENOSON (ADENOSINE RECEPTOR agonist) |
|
|
 |
Nexopamil (racemate) |
116759-35-4 |
C24H40N2O3 |
|
|
CC-223 (MTOR inhibitor) |
|
|
|
|
WESTERN antibody eluate |
|
|
 |
N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-3'-O-tert-butyldimethylsilyl guanosine |
81256-89-5 |
C41H51N5O8Si |
 |
H-GLU-ILE-GLY-ASP-GLU-GLU-ASN-SER-ALA-LYS-PHE-PRO-ILE-NH2 |
125934-45-4 |
C63H98N16O23 |
|
|
PMSF(100mM) |
|
|
 |
1-(2-シクロプロピルフェノキシ)-3-(イソプロピルアミノ)-2-プロパノール |
27325-36-6 |
C15H23NO2 |
|
|
AGAR (agar powder) |
|
|
 |
BDA-366 |
1909226-00-1 |
C24H29N3O4 |
|
|
NS-2028 (SGC inhibitor) |
|
|
|
|
AC480 (BMS-599626) (HER1 inhibitor) |
|
|
|
|
E-64 (CYSTEINE PROTEASE inhibitor) |
|
|
 |
3β-ヒドロキシ-20-オキソプレグナ-5-エン-16α-カルボニトリル |
1434-54-4 |
C22H31NO2 |
|
|
ARN-509 (ANDROGEN RECEPTOR Inhibitor) |
|
|
 |
1-ナフチルアセチルスペルミン 三塩酸塩 |
1049731-36-3 |
C22H35ClN4O |
|
|
PFI-1 (BET inhibitor) |
|
|
|
|
ICOTINIB HCL (EGFR inhibitor) |
|
|